Global Biotechnology Market is Expected to Reach US$414.5 bn by 2017


Posted July 6, 2016 by MarketTrends

The biotechnology market is primarily driven by the regulatory support provided by governments of various countries, increasing food demand, advancement of technology to combat fatal diseases and depleting natural resources.

 
As per the research conducted by seasoned industry analysts, the global biotechnology market had been in a major slump due to the recession faced by economies in the previous decade. In the years immediately after the recession ended, consumers were still shying away from foods and nutrition products that were not a part of the essential diet. This low demand had created a much lower revenue stream for the global biotechnology market and consequently cut back the investment rates into the market.

In the recent few years, however, the demand for similar foods and beverages has gone up, thereby boosting the need for the global biotechnology market. Biotech is currently in high demand from the sectors of pharma and agriculture. Apart from this high demand, a large number of biotech-related industries have sped up their innovation processes in order to be on top of the new product lineups.

Avail a Free Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=498

The major applications involved in the global biotechnology market are bio industrial, bio services, bio agriculture, and bio pharma. Nearly 60% of the global biotechnology market was occupied by biopharmaceuticals in 2011, owing to a substantially high amount of government funding and support.

Geographically speaking, the global biotechnology market was led by North America in 2011, when it held a share of 42%. Major trends leading to this top share were the high focus on renewable chemicals and an overall higher demand for biotech related products. At the same time, Asia Pacific is showing the fastest growth rate in the given forecast period, due to a significantly lower cost of conducting clinical trials in this region.

The Asia Pacific biotechnology market prospered especially from the booming growth of contract research organizations that are directly linked to clinical trials. This segment is showing a growth rate of more than 20% in the Asia Pacific biotech market.

A few of the key players in the report are Biogen Idec, Inc., Sanofi-Aventis, Pfizer, Roche, Novartis, Merck, GSK, Amgen, Inc., and Abbott Laboratories. Each key player is described on the basis of their business profile and strategies, along with the analysis of their financial structures, a SWOT analysis, and the most recent developments they have made.

Browse Full Research Report: http://www.transparencymarketresearch.com/biotechnology-market.html

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MarketTrends
Website Biotechnology Market
Phone +1-518-618-1030
Business Address State Tower, 90 State Street, Suite 700
Albany, NY 12207 United States
Country United States
Categories Health
Tags biotechnology market , global biotechnology market
Last Updated July 6, 2016